Clinical Trials Directory

Trials / Completed

CompletedNCT06363669

Effects of Caffeine-based Supplement on Physical Performance

Acute Effects of Multi-ingredient Pre-workout Dietary Supplement on Physical Performance in Untrained Men

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
12 (actual)
Sponsor
University School of Physical Education, Krakow, Poland · Academic / Other
Sex
Male
Age
19 Years – 30 Years
Healthy volunteers
Accepted

Summary

The aim of the study was to determine the acute effects of multi-ingredient pre-workout supple-ment (MIPS) containing: beta-alanine, taurine, caffeine, L-tyrosine, and cayenne pepper (capsaicin) on physical performance in untrained men

Detailed description

The aim of our study was to determine the acute effects of commercially available multi-ingredient pre-workout supple-ment (MIPS) containing: beta-alanine, taurine, caffeine, L-tyrosine, and cayenne pepper (capsai-cin) on physical performance in untrained men. The aerobic and anaerobic capacity was determined after ingestion of MIPS. A randomized, crossover, single-blind design was used to evaluate the effects of the dietary supplement on physical performance. The participants performed the exercise test twice, in random order: as a control test and after supplement administration (MIPS). The measurements took place over two consecutive days. Somatic measurements were taken on the same day that the first all-out test was performed. Twelve young healthy men, without medical contraindications to supramaximal and maximal intensity exercise, participated in the study. The exercise tests took place under medical supervision.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTmulti-ingredient pre-workout dietary supplement (caffeine-based)The participants performed the exercise twice, in random order: as a control test and after supplement administration. The acute effects of MIPS supplementation (beta-alanine 3000 mg, taurine 1000 mg, caffeine 290 mg, L-tyrosine 125 mg, and cayenne pepper extract (Capsicum annuum L.) 4.2 mg (of which 8% capsaicin)) on aerobic and anaerobic performance were evaluated in untrained men

Timeline

Start date
2018-01-15
Primary completion
2024-03-30
Completion
2024-03-30
First posted
2024-04-12
Last updated
2024-04-12

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT06363669. Inclusion in this directory is not an endorsement.